[Frontiers in Bioscience 2, d298-308, June 15, 1997]

Table of Conents
 Previous Section   Next Section


John M. Taylor and Jianglin Fan

Gladstone Institute of Cardiovascular Disease, the Department of Physiology, and the Cardiovascular Research Institute, University of California, San Francisco, CA


1. Duff, G. L. Experimental cholesterol arteriosclerosis and its relationship to human arteriosclerosis. Arch. Pathol. 20, 81-123, 259-304 (1935)

2. Clarkson, T. B., Lehner, N. D. M., and Bullock, B. C. Specialized research applications: I. Arteriosclerosis research. In The Biology of the Laboratory Rabbit. (Weisbroth, S. H., Flatt, R. E., and Kraus, A. L., eds.) pp. 155-165, Academic Press, San Diego (1974)

3. Kritchevsky, D. Role of cholesterol vehicle in experimental atherosclerosis. Am. J. Clin. Nutr. 23, 1105-1110 (1970)

4. Schwenke, D. C., and Carew, T. E. Initiation of atherosclerotic lesions in cholesterol-fed rabbits. I. Focal increases in arterial LDL concentration precede development of fatty streak lesions. Arteriosclerosis 9, 895-907 (1989)

5. Guyton, J. R., and Klemp, K. F. Early extracellular and cellular lipid deposits in aorta of cholesterol-fed rabbits. Am. J. Pathol. 141, 925-936 (1992)

6. Daley, S. J., Herderick, E. E., Cornhill, J. F., and Rogers, K. A. Cholesterol-fed and casein-fed rabbit models of atherosclerosis. Part 1: Differing lesion area and volume despite equal plasma cholesterol levels. Arterioscler. Thromb. 14, 95-104 (1994)

7. Daley, S. J., Klemp, K. F., Guyton, J. R., and Rogers, K. A. Cholesterol-fed and casein-fed rabbit models of atherosclerosis. Part 2: Differing morphological severity of atherogenesis despite matched plasma cholesterol levels. Arterioscler. Thromb. 14, 105-114 (1994)

8. Schwenke, D. C., and Carew, T. E. Initiation of atherosclerotic lesions in cholesterol-fed rabbits. II. Selective retention of LDL vs. selective increases in LDL permeability in susceptible sites of arteries. Arteriosclerosis 9, 908-918 (1989)

9. Herrmann, R. A., Malinauskas, R. A., and Truskey, G. A. Characterization of sites with elevated LDL permeability at intercostal, celiac, and iliac branches of the normal rabbit aorta. Arterioscler. Thromb. 14, 313-323 (1994)

10. Ross, R. The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature 362, 801-809 (1993)

11. Prior, J. T., Kurtz, D. M., and Ziegler, D. D. The hypercholesteremic rabbit. An aid to understanding arteriosclerosis in man? Arch. Pathol. 71, 672-684 (1961)

12. Chapman, M. J. Animal lipoproteins: Chemistry, structure, and comparative aspects. J. Lipid Res. 21, 789-853 (1980)

13. Fan, J., Wang, J., Bensadoun, A., Lauer, S. J., Dang, Q., Mahley, R. W., and Taylor, J. M. Overexpression of hepatic lipase in transgenic rabbits leads to a marked reduction of plasma high density lipoproteins and intermediate density lipoproteins. Proc. Natl. Acad. Sci. USA 91, 8724-8728 (1994)

14. Shore, V. G., Shore, B., and Hart, R. G. Changes in apolipoproteins and properties of rabbit very low density lipoproteins on induction of cholesteremia. Biochemistry 13, 1579-1585 (1974)

15. Thompson, K. H., and Zilversmit, D. B. Plasma very low density lipoprotein (VLDL) in cholesterol-fed rabbits: Chylomicron remnants or liver lipoproteins? J. Nutr. 113, 2002-2010 (1983)

16. MacKinnon, A. M., Savage, J., Gibson, R. A., and Barter, P. J. Secretion of cholesteryl ester-enriched very low density lipoproteins by the liver of cholesterol-fed rabbits. Atherosclerosis 54, 145-155 (1985)

17. Kovanen, P. T., Brown, M. S., Basu, S. K., Bilheimer, D. W., and Goldstein, J. L. Saturation and suppression of hepatic lipoprotein receptors: A mechanism for the hypercholesterolemia of cholesterol-fed rabbits. Proc. Natl. Acad. Sci. USA 78, 1396-1400 (1981)

18. Dietschy, J. M., and Wilson, J. D. Regulation of cholesterol metabolism (first of three parts). N. Engl. J. Med. 282, 1128-1138 (1970)

19. Dietschy, J. M., and Wilson, J. D. Regulation of cholesterol metabolism (second of three parts). N. Engl. J. Med. 282, 1179-1183 (1970)

20. Dietschy, J. M., and Wilson, J. D. Regulation of cholesterol metabolism (third of three parts). N. Engl. J. Med. 282, 1241-1249 (1970)

21. Mahley, R. W. Atherogenic lipoproteins and coronary artery disease: Concepts derived from recent advances in cellular and molecular biology. Circulation 72, 943-948 (1985)

22. Beynen, A. C., Van der Meer, R., and West, C. E. Mechanism of casein-induced hypercholesterolemia: Primary and secondary features. Atherosclerosis 60, 291-293 (1986)

23. Krause, B. R., Pape, M. E., Kieft, K., Auerbach, B., Bisgaier, C. L., Homan, R., and Newton, R. S. ACAT inhibition decreases LDL cholesterol in rabbits fed a cholesterol-free diet. Marked changes in LDL cholesterol without changes in LDL receptor mRNA abundance. Arterioscler. Thromb. 14, 598-604 (1994)

24. Kita, T., Brown, M. S., Bilheimer, D. W., and Goldstein, J. L. Delayed clearance of very low density and intermediate density lipoproteins with enhanced conversion to low density lipoprotein in WHHL rabbits. Proc. Natl. Acad. Sci. USA 79, 5693-5697 (1982)

25. Havel, R. J., Kita, T., Kotite, L., Kane, J. P., Hamilton, R. L., Goldstein, J. L., and Brown, M. S. Concentration and composition of lipoproteins in blood plasma of the WHHL rabbit. An animal model of human familial hypercholesterolemia. Arteriosclerosis 2, 467-474 (1982)

26. Buja, L. M., Kita, T., Goldstein, J. L., Watanabe, Y., and Brown, M. S. Cellular pathology of progressive atherosclerosis in the WHHL rabbit. An animal model of familial hypercholesterolemia. Arteriosclerosis 3, 87-101 (1983)

27. Nordestgaard, B. G., Tybjærg-Hansen, A., and Lewis, B. Influx in vivo of low density, intermediate density, and very low density lipoproteins into aortic intimas of genetically hyperlipidemic rabbits. Roles of plasma concentration, extent of aortic lesion, and lipoprotein particle size as determinants. Arterioscler. Thromb. 12, 6-18 (1992)

28. Overturf, M. L., Smith, S. A., Hewett-Emmett, D., Loose-Mitchell, D. S., Soma, M. R., Gotto, A. M., Jr., and Morrisett, J. D. Development and partial metabolic characterization of a dietary cholesterol-resistant colony of rabbits. J. Lipid Res. 30, 263-273 (1989)

29. Poorman, J. A., Buck, R. A., Smith, S. A., Overturf, M. L., and Loose-Mitchell, D. S. Bile acid excretion and cholesterol 7-alpha-hydroxylase expression in hypercholesterolemia-resistant rabbits. J. Lipid Res. 34, 1675-1685 (1993)

30. Soma, M. R., Morrisett, J. D., Gotto, A. M., Jr., Loose-Mitchell, D. S., Poorman, J. A., Smith, S. A., and Overturf, M. L. Cholesterol metabolism in fibroblasts from rabbits resistant to diet-induced hypercholesterolemia. J. Lipid Res. 31, 985-994 (1990)

31. Fox, R. R. Taxonomy and genetics. In The Biology of the Laboratory Rabbit. (Weisbroth, S. H., Flatt, R. E., and Kraus, A. L., eds.) Academic Press, San Diego, pp. 1-22 (1974)

32. Donnelly, T. M., Kelsey, S. F., Levine, D. M., and Parker, T. S. Control of variance in experimental studies of hyperlipidemia using the WHHL rabbit. J. Lipid Res. 32, 1089-1098 (1991)

33. Hagen, K. W. Colony husbandry. In The Biology of the Laboratory Rabbit. (Weisbroth, S. H., Flatt, R. E., and Kraus, A. L., eds.) pp. 23-47, Academic Press, San Diego. (1974)

34. Hammer, R. E., Pursel, V. G., Rexroad, C. E., Jr., Wall, R. J., Bolt, D. J., Ebert, K. M., Palmiter, R. D., and Brinster, R. L. Production of transgenic rabbits, sheep and pigs by microinjection. Nature 315, 680-683 (1985)

35. Hammer, R. E., Pursel, V. G., Rexroad, C. E., Jr., Wall, R. J., Bolt, D. J., Palmiter, R. D., and Brinster, R. L. Genetic engineering of mammalian embryos. J. Anim. Sci. 63, 269-278 (1986)

36. Knight, K. L., Spieker-Polet, H., Kazdin, D. S., and Oi, V. T. Transgenic rabbits with lymphocytic leukemia induced by the c-myc oncogene fused with the immunoglobulin heavy chain enhancer. Proc. Natl. Acad. Sci. USA 85, 3130-3134 (1988)

37. Massoud, M., Bischoff, R., Dalemans, W., Pointu, H., Attal, J., Schultz, H., Clesse, D., Stinnakre, M.-G., Pavirani, A., and Houdebine, L.-M. La production de protéines humaines dans le sang d'animaux transgéniques. (The production of human proteins in the blood of transgenic animals) (abstract and abridged version in English). C. R. Acad. Sci. Paris III 311, 275-280 (1990)

38. Weidle, U. H., Lenz, H., and Brem, G. Genes encoding a mouse monoclonal antibody are expressed in transgenic mice, rabbits and pigs. Gene 98, 185-191 (1991)

39. Peng, X., Olson, R. O., Christian, C. B., Lang, C. M., and Kreider, J. W. Papillomas and carcinomas in transgenic rabbits carrying EJ-ras DNA and cottontail rabbit papillomavirus DNA. J. Virol. 67, 1698-1701 (1993)

40. Warren, R. J., Ebert, D. L., Mitchell, A., and Barter, P. J. Rabbit hepatic lipase cDNA sequence: Low activity is associated with low messenger RNA levels. J. Lipid Res. 32, 1333-1339 (1991)

41. Olivecrona, T., and Bengtsson-Olivecrona, G. Lipoprotein lipase and hepatic lipase. Curr. Opin. Lipidol. 1, 222-230 (1990)

42. Rothblat, G. H., Mahlberg, F. H., Johnson, W. J., and Phillips, M. C. Apolipoproteins, membrane cholesterol domains, and the regulation of cholesterol efflux. J. Lipid Res. 33, 1091-1097. (1992)

43. Kadowaki, H., Patton, G. M., and Robins, S. J. metabolism of high density lipoprotein lipids by the rat liver: Evidence for participation of hepatic lipase in the uptake of cholesteryl ester. J. Lipid Res. 33, 1689-1698 (1992)

44. Ji, Z.-S., Lauer, S. J., Fazio, S., Bensadoun, A., Taylor, J. M., and Mahley, R. W. Enhanced binding and uptake of remnant lipoproteins by hepatic lipase-secreting hepatoma cells in culture. J. Biol. Chem. 269, 13429-13436 (1994)

45. Sanan, D. A., Fan, J., Bensadoun, A., and Taylor, J. M. Hepatic lipase is abundant on both hepatocyte and endothelial cell surfaces in the liver. J. Lipid Res. 38, 1002-1013.

46. Mahley, R. W. Apolipoprotein E: Cholesterol transport protein with expanding role in cell biology. Science 240, 622-630 (1988)

47. Thuren, T., Weisgraber, K. H., Sisson, P., and Waite, M. Role of apolipoprotein E in hepatic lipase catalyzed hydrolysis of phospholipid in high-density lipoproteins. Biochemistry 31, 2332-2338 (1992)

48. Simonet, W. S., Bucay, N., Lauer, S. J., and Taylor, J. M. A far-downstream hepatocyte-specific control region directs expression of the linked human apolipoprotein E and C-I genes in transgenic mice. J. Biol. Chem. 268, 8221-8229 (1993)

49. Fan, J., McCormick, S. P. A., Krauss, R. M., Taylor, S., Quan, R., Taylor, J. M., and Young, S. G. Overexpression of human apolipoprotein B-100 in transgenic rabbits results in increased levels of LDL and decreased levels of HDL. Arterioscler. Thromb. Vasc. Biol. 15, 1889-1899 (1995)

50. Linton, M. F., Farese, R. V., Jr., Chiesa, G., Grass, D. S., Chin, P., Hammer, R. E., Hobbs, H. H., and Young, S. G. Transgenic mice expressing high plasma concentrations of human apolipoprotein B100 and lipoprotein(a). J. Clin. Invest. 92, 3029-3037 (1993)

51. Yamanaka, S., Balestra, M. E., Ferrell, L. D., Fan, J., Arnold, K. S., Taylor, S., Taylor, J. M., and Innerarity, T. L. Apolipoprotein B mRNA-editing protein induces hepatocellular carcinoma and dysplasia in transgenic animals. Proc. Natl. Acad. Sci. USA 92, 8483-8487 (1995)

52. Yamanaka, S., Poksay, K. S., Arnold, K. S., and Innerarity, T. L. A novel translational repressor mRNA is edited extensively in livers containing tumors caused by the transgene expression of the apoB mRNA-editing enzyme. Genes Dev. 11, 321-333 (1997)

53. Duverger, N., Emmanuel, F., Viglietta, C., Tailleux, A., Benoit, P., Attenot, F., Cuiné, S., Fievet, C., Laine, B., Fruchart, J. C., Houbebine, L. M., and Denèfle, P. Human apolipoprotein A-I gene transfer in the rabbit: Incidence on atherogenesis. Circulation 90, I-240 (abstr.) (1994)

54. Duverger, N., Viglietta, C., Berthou, L., Emmanuel, F., Tailleux, A., Parmentier-Nihoul, L., Laine, B., Fievet, C., Castro, G., Fruchart, J. C., Houbebine, L. M., and Denèfle, P. Transgenic rabbits expressing human apoliproprotein A-I in the liver. Arterioscler. Thromb. Vasc. Biol. 16, 1424-1429 (1996)

55. Duverger, N., Kruth, H., Emmanuel, F., Caillaud, J.-M., Viglietta, C., Castro, G., Tailleux, A., Fievet, C., Fruchart, J. C., Houdebine, L. M., and Denefle, P. Inhibition of atherosclerosis development in cholesterol-fed human apolipoprotein A-I-transgenic rabbits. Circulation 94, 713-717 (1996)

56. Hoeg, J. M., Vaisman, B. L., Demosky, S. J., Jr., Santamarina-Fojo, S., Brewer, H. B., Jr., Remaley, A. T., Hoyt, R. F., and Feldman, S. Development of transgenic Watanabe heritable hyperlipidemic rabbits expressing human apolipoprotein A-I. Circulation 88, I-2 (abstr.) (1993)

57. Hoeg, J. M., Vaisman, B. L., Demosky, S. J., Jr., Meyn, S. M., Talley, G. D., Hoyt, R. F., Jr., Feldman, S., Bérard, A. M., Sakai, N., Wood, D., Brousseau, M. E., Marcovina, S., Brewer, H. B., Jr., and Santamarina-Fojo, S., Lecithin: cholesterol acyltransferase overexpression generates hyperalpha-lipoproteinemia and a nonatherogenic lipoprotein pattern in transgenic rabbits. J. Biol. Chem. 271, 4396-4402 (1996)

58. Hoeg, J. M., Santamarina-Fojo, S.,Vaisman, B. L., Demosky, S.J., Jr., Hoyt, R. F., Jr., Feldman, S. H.,Talley, G., and Brewer, H.B., Jr. Overexpression of human lecithin-cholesterol acyl transferase in transgenic rabbits leads to hyperalphalipoproteinemia. Atherosclerosis 109, 11 (abstr.) (1994)

59. Hoeg, J. M., Santamarina-Fojo, S., Bérard, A. M., Cornhill, J. F., Herderick, E. E., Feldman, S. H., Haudenschild, C. C., Vaisman, B. L., Hoyt, R. F., Jr., Demosky, S. J., Jr., Kauffman, R. D., Hazel, C. M., Marcovina, S. M., and Brewer, H. B., Jr. Overexpression of lecithin:cholesterol acyltransferase in transgenic rabbits prevents diet-induced atherosclerosis. Proc. Natl. Acad. Sci. USA 93, 11448-11453 (1996)